With the Wimbledon finals taking place on its famous grass courts this weekend, allergy expert Dr Mohamed Shamji explains how there may be hope for hay fever sufferers.
Strawberries and cream, queuing and of course, tennis are all the things you would associate with the Wimbledon Tennis Championships that climaxes this week in London. This tournament traditionally marks the end of the grass court season, which for the relief of many hay fever sufferers also signals the grass pollen season is drawing to a close. Headlines, guidance and warnings about hay fever are abundant at this time of year due to the large socio-economic impact it presents and here at Imperial College London, we are hoping to reduce this through our research into the disease and how we can treat it. (more…)
To mark World AIDS Day 2017, we have published a series of blog posts to highlight the important and varied research that takes places at Imperial. Three experts from Faculty of Medicine share their interest in HIV/AIDS which spans from the elusive vaccine to the economics of the epidemic.
World AIDS Day takes place annually on 1 December as an opportunity for people worldwide to unite in the fight against HIV and to show support for people living with HIV/AIDS.
Where are we in the battle against HIV/AIDS?
The past thirty years have seen enormous gains. We’ve seen the development of highly effective therapy that today can ensure the health of an HIV positive individual for rest of their natural lifespan. We used to speak of HIV/AIDS as if they were the same thing, now you can be HIV positive and never develop AIDS (Acquired Immunodeficiency Syndrome). Globally over 18 million people are now receiving life-saving drugs, preventing millions of deaths each year. Treatment also dramatically reduces the risk of passing on the infection. Excitingly, recent studies have shown that taking a daily pill (known as pre-exposure prophylaxis or PrEP) can prevent people from contracting HIV infection and this is now being made available in the UK. (more…)
Originally published on the MRC Insight blog and reproduced under CC BY 4.0, here Peter Openshaw, Professor of Experimental Medicine at Imperial and President of the British Society for Immunology, says we cannot afford to be complacent about vaccines.
As a clinician working in research, I want to improve peoples’ health. The NHS was set up to focus on treating people with disease. But how much better would it be if we could prevent people from getting sick in the first place?
This is where vaccines come in. As vaccinologists, we use our scientific knowledge to design new or improved vaccines to stimulate the immune system. This creates natural protection against infections and prevents disease. (more…)